What is Vericel's stock-based comp?

Vericel (VCEL) reported stock-based comp of $11.29M in Q1 2026.

How has Vericel's stock-based comp changed year-over-year?

Vericel's stock-based comp decreased by 1.8% year-over-year, from $11.51M to $11.29M.

What is the long-term trend for Vericel's stock-based comp?

Over 4 years (2021 to 2025), Vericel's stock-based comp has grown at a 3.1% compound annual growth rate (CAGR), from $34.32M to $38.77M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Vericel VCEL Stock-Based Comp

Stock-Based Comp at other companies

StrykerSYK

$87M+3.6%

Zimmer Biomet HoldingsZBH

$24.2M+23.5%

LeMaitre VascularLMAT

$2.09M+2.2%

Capricor TherapeuticsCAPR

$5.92M+8.0%

Globus MedicalGMED

$12.62M-4.5%

Johnson & JohnsonJNJ

$300M+4.2%

Other financials

Income statement

See full

Revenue$68.4M+30.1%

Gross profit$49.3M+35.8%

Operating income-$8.1M+37.0%

Net income-$6.3M+44.0%

EPS (diluted)-$0.12+47.8%

Balance sheet

See full

Cash & equivalents$109.3M+37.1%

Total debt$95.0M-4.6%

Total equity$356.2M+20.6%

Total assets$485.6M+14.4%

Cash flow

See full

Operating cash flow$16.4M+148%

CapEx$1.3M-91.2%

Free cash flow$15.1M+299%

Valuation

See full

Market cap$2.13B-26.8%

Profitability

See full

Gross margin74.8%+2.3pp

Operating margin5.4%+4.6pp

Net margin7.3%+6.1pp

FCF margin16.3%—

Returns & leverage

See full

Return on equity6.6%+5.5pp

Debt / equity0.3×-0.1×

Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vericel's stock-based comp?: Vericel (VCEL) reported stock-based comp of $11.29M in Q1 2026.
How has Vericel's stock-based comp changed year-over-year?: Vericel's stock-based comp decreased by 1.8% year-over-year, from $11.51M to $11.29M.
What is the long-term trend for Vericel's stock-based comp?: Over 4 years (2021 to 2025), Vericel's stock-based comp has grown at a 3.1% compound annual growth rate (CAGR), from $34.32M to $38.77M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.